Tobias Justesen

7PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersElectrical energy generation (incl. renewables, excl. photovoltaics)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 05, 2026
Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial.

|Jan 14, 2025
Association Between Deficient MSH2/MSH6 Versus MLH1/PMS2 Status and Survival Rates in Localized Colorectal Cancer: A Nationwide Cohort Study.

Tobias Freyberg Justesen, Adile Orhan, Andreas Weinberger Rosen

|Dec 18, 2024
Neoadjuvant Pembrolizumab in Stages I-III Deficient Mismatch Repair Colon Cancer: A Clinical Trial.

Ismail Gögenur, Tobias Freyberg Justesen, Line Schmidt Tarpgaard

|Jun 24, 2022
Electroporation and Immunotherapy-Unleashing the Abscopal Effect.

Tobias Freyberg Justesen, Adile Orhan, Hans Raskov

Pageof 2